What relationship does my hon. Friend predict that the new commissioner will have with the National Institute for Health and Clinical Excellence, which recently decided not to approve quality of life improving drugs for people suffering from the early stages of Alzheimer’s disease? Increasing numbers of people are in need of those drugs, which also benefit their carers. People often suffer for many years because although their general health is good, those particular drugs have not been approved by NICE. Does my hon. Friend foresee that the commissioner will continue the campaign to try to get them approved?
Commissioner for Older People (Wales) Bill [Lords]
Proceeding contribution from
Angela Watkinson
(Conservative)
in the House of Commons on Thursday, 15 June 2006.
It occurred during Debate on bills on Commissioner for Older People (Wales) Bill (HL).
Type
Proceeding contribution
Reference
447 c933 
Session
2005-06
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2024-04-22 00:00:36 +0100
URI
http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_330630
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_330630
In Solr
https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_330630